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Abstract
Microarray based transcription profiling is now a consolidatedmethodology and has widespread use in areas such as
pharmacogenomics, diagnostics and drug target identification. Large-scale microarray studies are also becoming
crucial to a new way of conceiving experimental biology. A main issue in microarray transcription profiling is data
analysis and mining. When microarrays became a methodology of general use, considerable effort was made to
produce algorithms and methods for the identification of differentially expressed genes. More recently, the focus has
switched to algorithms and database development for microarray data mining. Furthermore, the evolution of micro-
array technology is allowing researchers to grasp the regulative nature of transcription, integrating basic expression
analysis with mRNA characteristics, i.e. exon-based arrays, and with DNA characteristics, i.e. comparative genomic
hybridization, single nucleotidepolymorphism, tiling andpromoter structure. In this article,wewill review approaches
used to detect differentially expressed genes and to link differential expression to specific biological functions.
Keywords: transcription; microarray; bioinformatics; statistics; pathways; transcription factors
INTRODUCTION
Microarray-based transcription profiling is now a
consolidated methodology and large-scale microar-
ray studies are becoming a crucial aspect of a new
way of conceiving experimental biology. Microarray
technology started as two-channel technology [1, 2],
i.e. simultaneous hybridization of two different sam-
ples performed on the same array. However, single-
channel technology, i.e. a RNA sample hybridized
on a single array, has more recently become the
preferred approach, due to the simpler and flexible
experimental design [3, 4].
Within the commercial single channel microarray
platforms available on the market, Affymetrix (www.
affymetrix.com) is the older, with the largest panel of
microarray designed for a variety of different organ-
isms and the higher number of public available data
sets (www.ncbi.nlm.nih.gov/geo/; www.ebi.ac.uk/
microarray-as/aer/?#ae-main[0]). Affymetrix micro-
arrays are based on chemical synthesis of 25 mer
oligonucleotides in 11-5 mm2 features on glass slides.
The high density of oligonucleotides provides
adequate space on the chip for use of multiple
probes per mRNA transcript. The arrays based on
11 mm2 features are also called 30 based expression
arrays (30 IVT arrays) since each transcript is queried
by a probe set, made up of 11 probe pairs mapping on
600 bases of the most 30 end of the transcript. More
recently, Affymetrix started the production of arrays
based on 5 mm2 features. The higher density array
manufacturing capability enabled the profiling of
exon-level expression at the whole-genome scale on a
single array (Exon 1.0 ST). In these arrays, each exon
is queried by four probes. This technological
improvement allowed also the production of arrays
where each transcript is queried using 26 probes
spread across the full length of the gene (Gene 1.0 ST
arrays), providing a more complete and more accurate
picture of gene expression than 30-based expression
array designs. A comparison study between 30 IVT
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and the new exon platform was recently published
[5], indicating that, despite several major technologi-
cal changes, a high concordance between the two
platforms can be observed and the median relative
sensitivity is similar in both platforms.
More recently, Illumina (www.illumina.com) has
become increasingly popular within the scientific
community due to some features of its arrays: long
oligonucleotides, probe replication, reduced per
hybridization cost, etc. Illumina have created a
microarray technology (Bead-Array) based on ran-
domly arranged beads. A specific oligonucleotide
sequence is assigned to each bead type, which is
replicated on the average about 30 times on an array.
A series of decoding hybridizations is used to identify
every bead [6]. The high degree of replication makes
robust measurements for each bead type possible.
The BeadChip technology comprises a series of
rectangular strips on a slide, each strip containing
about 24 000 bead types.
Measured independently by the type of single
channel array in use, the main issue in microarray
experiment is data analysis and the consequent
extraction of biological knowledge. Transcriptome
analysis is complicated by multiple factors such as the
limited number of possible experiment replications
which is always lower than the number of variables,
i.e. genes under investigation, or the actual limited
knowledge of gene regulation and gene product
function. Furthermore, in microarray analysis, it is
not possible to identify any specific piece of software
that is globally accepted by the scientific community
as the gold standard for microarray data analysis. It is
clear however that any microarray data analysis can
be summarized in four main steps and each step can
be completed using different computational tools:
(i) quality control
(ii) data pre-processing:
 microarray-specific background subtraction
 experiment-specific background subtraction
 transcript intensity summary
 removal of non-significant transcripts
(iii) differential expression detection
(iv) biological knowledge extraction
QUALITYCONTROL
Quality control (QC) is a very important step of
microarray analysis. Essentially, qualiy control could
be divided in two subareas:
 Detection of array artifacts and outliers.
 Evaluation of the homogeneity of experimental
groups.
Furthermore, QC is strongly depended on the
microarray platform in use.
In Affymetrix 30 IVT arrays, each transcript is
represented by a probe set made of 11–20 probes
pairs. Each probe pair is made of PM andMM probes.
One probe designed to perfectly match the target
transcript (PM probe) and the other designed to
measure the non-specific binding signal of its partner
PM probe. The mismatch (MM) probe is identical to
its partner PM probe except for the central (13th)
nucleotide, which is changed to the complementary
base. PMs and MMs are used by the Liu’s algorithm
[7] to determine whether the transcript of a gene is
detected (present) or undetected (absent).
As basic QC, Affymetrix suggests a certain
number of checks to be performed at the level of
each array (see Affymetrix manual: data_analysis_
fundamentals_manual). These checks include:
 Average background and noise, which is a measure
of the pixel-to-pixel variation of probe cells on a
GeneChip array, (proposed correct range: 20–100).
 The number of probe sets called present relative
to the total number of probe sets on the array
and replicate samples should have similar percent
present values.
 Poly-A RNA spiked-in controls are used to
monitor the entire target labelling process and
should be all called present.
 Eukaryotic hybridization controls are spiked into
the hybridization cocktail, independent of RNA
sample preparation, and are thus used to evaluate
sample hybridization efficiency on eukaryotic
gene expression arrays. They should be called
present at least 50% of the time.
 b-actin and GAPDH are used to assess RNA
sample and assay quality. Specifically, the signal
values of the 30 probe sets for actin and GAPDH
are compared to the signal values of the corres-
ponding 50 probe sets. The ratio of the 30 probe set
to the 50 probe set is generally no more than three
for the one-cycle assay.
Furthermore, Bioconductor package affyPLM
(www.bioconductor.org) allows to perform a
Probe Level Model (PLM) fitting. PLM is a model
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that is fitted to probe-intensity data. The model is
fitted with probe level and chip level parameters
on a probe set by probe set basis. In quality control
chip level, parameters are a factor variable with a
level for each array. The PLM model can be
used to plot relative Log expression (RLE) values,
which are computed for each probe set by compar-
ing the expression value on each array against the
median expression value for that probe set across all
arrays. Assuming that most genes are not changing in
expression across arrays means ideally most of these
RLE values will be near 0. Another QC plot that can
be produced using PLM data is normalized unscaled
standard errors (NUSE). The standard error estimates
obtained for each gene on each array are taken and
standardized across arrays so that the median standard
error for that gene is 1 across all arrays. This process
accounts for differences in variability between
genes. An array where there are elevated SE relative
to the other arrays is typically of lower quality.
Bioconductor packages AffyExpress, affyQCReport
also offer the possibility to produce various types of
quality controls.
Concerning Illumina arrays BeadStudio allows
the generation of a graphical control summary report
based on performance of built-in controls (positive/
negative hybridization beads, specificity hybridiza-
tion signals, etc). Bioconductor package beadarray
[8] offers some other QC tools. The package has the
ability to read the raw data produced from BeadScan.
Boxplots, density plots and image plots are generated
automatically and summarized in an HTML report
and could be used to identify outlier arrays. The
limiting issue of this useful package is the large
amounts of computer memory required to run these
analyses. The lumi package also provides bead level
Illumina microarray data analysis. The package
covers data input, quality control, variance stabiliza-
tion, normalization and gene annotation. In parti-
cular, the quality control of a LumiBatch object
includes a data summary (the mean and standard
deviation, sample correlation, detectable probe ratio
of each sample) and different quality control plots
(boxplots, density plots, pairwise MA or sample
correlation).
Furthermore, principal component analysis
(PCA) [9] as well as hierarchical clustering [10] can
offer a graphical view of the homogeneity of
experimental groups and are available in many
Bioconductor packages, e.g. oneChannelGUI [11]
and lumi.
DATA PRE-PROCESSING
Pre-processing is the process that allows the trans-
formation of the raw fluorescence signal detected by
microarray staining into a signal normalized for
experimental errors.
The main steps of pre-processing are: background
subtraction, experiment normalization, transcript
intensity summarization, removal of non-informative
and not expressed transcripts.
The first three steps of data pre-processing
(i.e. background subtraction, experiment normal-
ization, transcript intensity summarization) are
usually combined together in a unique algorithm as
in the case of Affymetrix arrays, where the intensities
of multiple short probes need to be combined to
generate transcript expression level; or in Illumina
bead arrays, where the intensities of multiple copies
of the same long probe, used to the detect the same
transcript, need to be summarized to the average
transcript expression level. It should be noted that
for the development of summarization algorithms,
publicly available dilution experiments as well
as spike-in experiments are extremely important as
benchmarks in the testing of sensibility
and specificity of the algorithms. Both types of
benchmark experiments are available for Affymetrix
arrays (www.affymetrix.com) whereas for Illumina
bead arrays only a few dilution experiments are
available [12].
Much has been published on data pre-processing
for Affymetrix 30 IVT array [13], due to the fact
that each transcript is described by a group of short
25-mer probes (probe set) and it is necessary to
summarize the probe set intensity by taking into
consideration various types of noise.
Affymetrix defined an empirical method for
summarization of differential expression [14] imple-
mented in the MAS 5.0 software package (www.
affymetrix.com/support/technical/technotes/statisti
cal_reference_guide.pdf). The algorithm is based on
the specific construction of 30 IVT Affymetrix arrays
(see above) probe set signal is calculated using
the One-Step Tukey’s Biweight Estimate [14],
which yields a robust weighted mean that is
relatively insensitive to outliers, even when extreme.
The mismatch intensity is used to estimate stray
signal. The real signal is estimated by taking the log
of the PM intensity after subtracting the stray signal
estimate. Stray signal estimate is equal to MM when
the MM intensity is lower than the PM intensity.
In case of MM values higher than PM values,
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an imputed value called change threshold (CT) is
used instead of the uninformative MM. If the MM
probe cells are generally informative across the probe
set except for a few MM, CT is an adjusted MM
value based on the bi-weight mean of the PM and
MM ratio. If the MM probe cells are generally
uninformative, CT is given by a value that is slightly
smaller than the PM.
The probe set summary methods currently used
widely by the scientific community are mainly
model-based methods. These methods model
probe set summaries using the information
derived from a multi array experiment. The disper-
sion of the probe set probes in various locations of
the array makes the Affymetrix arrays somewhat
insensitive to local constructions/hybridization
artifacts.
However, an important issue of probe set sum-
marization using 25-mer probes is the definition of
the sequence-dependent non-specific hybridization.
RMA methodology [15] performs background
correction, normalization and summarization in a
modular way, but it does not take into account non-
specific probe hybridization in probe set background
calculation. GCRMA [16] is instead an extension of
RMA with a background correction component,
which makes use of probe sequence information.
More recently, Affymetrix proposed the probe
logarithmic error intensity estimate (PLIER)
method which produces an improved signal by
accounting for experimentally observed patterns in
probe behaviour and handling errors at the appro-
priately low and high-signal values (www.affy
metrix.com). Methods such as PLIER and GCRMA,
which use model-based background correction,
maintain relatively good accuracy without losing
much precision. PLIER is also superior to other
algorithms in avoiding false positives with poorly
performing probe sets [17]. Seo and Hoffmann [17]
however highlight the fact that background is a very
complex variable and cannot be perfectly estimated.
It is therefore not feasible to identify the ‘best’ probe
set algorithm, but this should be defined on the basis
of the type of project. A confirmation of the
importance to select probe set algorithm on the
basis of the experiment type comes from a recent
paper [18] shows that MAS5 is the best choice in
reverse engineering studies of cellular networks,
since a crucial step of GCRMA algorithm is
responsible for a systematic overestimation of pair-
wise correlation, which instead does not affect the
detection of differential expression in two and
multiple class experiments.
Data pre-processing for Illumina data is relatively
simple, mainly because multiple replications of one
long oligonucleotide are used to detect the 30 end of
a transcript. The use of long oligonucleotides greatly
reduces the non-specific hybridization problem [19]
present in Affymetrix arrays. Furthermore, the
average 30-fold bead-type redundancy strongly
reduces local hybridization artefacts. Pre-processing
of Illumina arrays can be performed using Illumina
BeadStudio software (www.illumina.com). Bead
Studio produces an average value for each bead
type on the un-logged scale and provides various
normalization and visualization tools. However,
loose information is given about replicates of each
bead type, data are automatically background
corrected and there is no possibility of controlling
image processing. Before summarization, BeadStudio
detects as outliers all beads of the same type that have
an un-logged intensity of more than three median
absolute deviations (MAD) and does not include
them in intensity summarization. Background is
measured for all beads as the mean of the negative
controls on an array and is used by BeadStudio
software to perform background normalization.
Recently, an open source tool [8, 20] allowing the
bead-level data handling of Illumina bead arrays
improved the flexibility of the Illumina summariza-
tion algorithm. In the beadarray package [8] available
in Bioconductor [21], the detection of outliers can
be done using either un-logged and logged inten-
sities and using a user defined number of MADs.
Dunning [20] has also shown that background values
for beads are virtually constant within arrays and also
across arrays. Local measure of background is
equivalent to global value, but background corrected
data show much more variability among beads of the
same type [20]. This observation therefore suggests
the use of the automatic background correction
available in BeadStudio be avoided [20]. Log
intensity transformation is another part of the pre-
processing that can be applied both to Affymetrix
and Illumina arrays, and is used to reduce variance
and improve precision [20, 22–24]. However, it
should be used carefully since the increased precision
of log transformation could be at the expense of
levels of accuracy [22, 25].
During data generation, numerous factors could
alter the outcome through the introduction of sys-
tematic biases. Those are mainly linked to the limited
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control that the experimenter has on biological
objects, i.e. cell cultures, biopsies, reagents, etc., or to
the presence of overall disparities of slide surfaces
and variation in manufacturing as well as scanner-
introduced bias, which influence the RNA quanti-
fication process. As a means of identifying and
removing systematic biases, data normalization is
typically performed.
Global median normalization is usually not rec-
ommended since the simple adjustment of the
median intensity value within each array does not
take into account local intensity bias. Global loess
normalization is instead used to address intensity-
dependent bias [26, 27].
The loess method was initially proposed by Yang
[27]. This approach stems from the M versus A plot,
where M is the difference in log expression values
and A is the average of those. A normalization curve
is fitted to this M versus A plot by using loess, which
is a method of local regression. The fits based on the
normalization curve are subsequently subtracted
from the M values. This method was extended to
single channel arrays by Bostald [26]. In his imple-
mentation, each array is normalized against all the
others for one or two iterations.
A normalization method widely used for single
channel arrays is the quantile [26]. The goal of the
quantile method is to make the distribution of probe
intensities for each of a set of arrays the same. The
idea behind the method is that a quantile–quantile
plot shows that the distribution of two data vectors is
the same if the plot is a straight diagonal line, but not
if it is other than a diagonal. This concept can be
extended to n dimensions if more than two arrays
are available. This suggests that an n set of data can be
made to have the same distribution by projecting
the points of the n-dimensional quantile plot onto
the diagonal. However, according to very recent
results, this normalization method can have an
impact on the biological variability and, therefore,
appears to be less than optimal from this point of
view [28].
A method for the normalization of Illumina bead
arrays other than quantile available in the beadStudio
is the cubic spline method. This method is similar
to the one proposed by Workman [29]. The nor-
malization uses quantiles of sample intensities to fit
smoothing B-splines. For each sample, its vector of
quantile intensities as well as quantiles for the ‘virtual’
averaged sample after background subtraction are
computed. Cubic B-spline is than computed and
used for interpolation. Furthermore, the Biocon-
ductor lumi package supports directly reading of the
Illumina Bead Studio toolkit. It contains a variance-
stabilizing transformation algorithm that takes
advantage of the technical replicates available on
every Illumina microarray and a robust spline
normalization algorithm, which combines the fea-
tures of the quantile and loess normalization.
All these methods are based on the assumption
that the majority of elements should be not differen-
tially expressed. A recent paper [30] has described a
normalization method called orthogonal projections
to latent structures (OPLS), which the authors claim
to be independent from the previous assumption.
This method identifies joint variation within bio-
logical samples, allowing the removal of sources of
variation that do not correlate with the within-
sample variation. This ensures that the structured
variation related to the underlying biological samples
is separated from the remaining bias-related sources
of systematic variation.
A problem in microarray data analysis is the high
dimensionality of gene expression space, which
prohibits a comprehensive statistical analysis without
focusing on particular aspects of the joint distribution
of the gene expression levels. A theoretical compu-
tation [31] showed that there is an optimal number
of hypotheses to be tested which is limited by
the number of samples in the experiment. When
the proportion of differentially expressed transcripts
is small, they tend to get buried among the non-
differentially expressed. Possible strategies to over-
come this problem are to undertake some kind of
biology-driven filtering or to perform signal-driven
filtering of genes before the actual statistical analysis
[32–34].
Although the integration of biological knowledge
is usually associated with the data mining process
[35, 36], the use of biology-driven filters could be
an ideal choice when the experimenter has a
clear idea of which subarea of biology should be
investigated at transcription level by microarray
analysis. These types of filters are clearly dependent
on the availability of biological knowledge and on
the robustness of data annotation. The database
most used, which links biological information to
genes, is Gene Ontology (GO) [37], but many
other biology-driven ontologies have become
available in recent years [38], increasing the
number of biological topics to be used for biology-
driven filters.
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Non-informative signals, i.e. those characterized
by an expression close to background over all the
experimental points, can be detected, in the case of
30 IVT arrays, by detection (Present/Absent) call
algorithm (www.affymetrix.com). This is a p-score
that assesses the reliability of each expression level
and is produced using a signed rank test to consider
the significance of the difference between the PM
and MM values for each probe set [7]. This approach
could be used to remove data that are not reliably
detected, before further analysis [39]. McClintick
[39] also observed that the use of a filter based on
detection call removes probe sets contributing to a
disproportionate number of false positives. Experi-
ment size does however greatly affect the ability to
reproducibly detect significant differences, and also
impacts on the effect of filtering, i.e. small experi-
ments based on 3–5 samples per treatment group
benefit from more restrictive filtering (50%
present). A similar filtering approach could be
applied to Illumina arrays using the detection score,
which is given by R/N, where R is the rank of the
gene signal relative to negative controls and N is the
number of negative controls.
A generally applicable filtering approach called
the IQR filter, which eliminates genes that do not
show sufficient variation in expression across all
samples, as they tend to provide little discriminatory
power, was proposed by von Heydebreck [32] and
could be used routinely to reduce the number of
hypothesis testing [40–43]. This filter is one of the
filters implemented in the Bioconductor package
genefilter (www.bioconductor.org) and allows the
removal of genes that do not show an expression
variation over all samples greater than a user defined
threshold. The strength of such filtering procedure
is palpable when applied to the Affymetrix latin
square experiments (Figure 1), where 42 probe sets
are spiked-in with concentrations ranging from
0.125 to 512 pM in a common background. This
example highlights the fact that invariant transcripts
can be easily eradicated, although an important issue
of this filtering approach is the homogeneity of the
experimental groups. This procedure, if applied to a
data set designed to identify cell cycle genes such as
Spellman [44], will be inefficient since the vast
majority of the genes are characterized by repetitive
wave-like fluctuations.
Figure 1: IQR filtering on HGU133A latin square experiments. Forty-two probe sets are spike-in at concentration
ranging from 0.125 to 512 pM in a common background. It removes all probe sets which are not characterized by a
broad inter-quantile range within the various samples. (A) Unfiltered complete set. (B) IQR filtering at 0.125. (C) IQR
filtering at 0.5.This has a tremendous effect in the spike-in experiments, since they are based on a concentration curve
from 0 to 512 pM.
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Extracting biological information from microarray
data requires appropriate statistical methods. Much
work has been done to optimize conventional
statistical tests to the limited experimental structure
usually available in microarray experiments. The
main issue in differential expression analysis is the
experiment group size, which is always smaller than
the number of tests (transcripts) to be investigated.
Due to the limited sample size of the majority of
experiments involving microarray analysis, statistical
tools simply work like a filter that highlights the most
significant differentially expressed transcripts, but do
not represent the ultimate validation of the differ-
ential expression. Transcripts detected by statistical
analysis need to get back to the wet laboratory to
confirm their differential expression. Furthermore,
the integration of different pre-processing steps
combined with different statistics does not necessarily
detect the same subset of differentially expressed
transcripts [45, 46].
Each combination of methods will attain some
but not all true signals (Figure 2). At the same time
each combination of methods will get some false
signals (Figure 2). The trick is to find the best
condition to maximize true signals, while minimiz-
ing fakes. However, the only way to define the best
combination of methods is to know the differential
expressed subset of transcripts, which is not known
since it is the goal of a differential expression analysis.
Using benchmark experiments, however, it is possi-
ble to evaluate the performances of different
methods [45, 47] in order to identify which
method better fits to a specific experimental
structure.
The works of Choe [47] and that of Jeffery [45]
investigate different aspects of differential expression
analysis. Choe compares the performances of two
moderated t-test statistics, significance analysis of
microarrays (SAM) [48] and CyberT [49] in the
identification of differentially expressed transcripts in
an experiment that resembles the vast majority of
microarray experiments designed to highlight the
transcriptional events involved in a biological treat-
ment. Jeffery evaluates the performances of SAM,
empirical bayes t-statistics [50], rank products [51]
and other statistics to select meaningful features to be
used for classification studies.
SAM is a well-known software within the
biological scientific community, in its t-statistic a
constant value is added to the standard deviation.
This constant is called the ‘fudge factor’ and it is
chosen to minimize the dependence of the t-statistic
variance on standard deviation levels. However, it
has been found that SAM does not control well
FDR [52–54]. A recent paper of Zhang [55] also
indicates that even the most recent improvements in
SAM (sam2.20) still produce erroneous and even
conflicting results under certain situations.
CyberT [49] models the standard deviation as
a function of signal intensity and its functionality
was further enhanced by other linear modelling
approaches such as that proposed by Smyth [50] and
implemented in the limma Bioconductor package.
In particular, CyberT was limited to two-sample
control versus treatment designs and its model did
not distinguish between differentially and non-
differentially expressed genes. Furthermore, CyberT
was not characterized by consistent estimators for the
hyperparameters [50] and the degrees of freedom
associated with the prior distribution of the variances
was set to a default value, while the prior variance
was simply equated to locally pooled sample
variances [50]. Despite these limitations, Choe’s
paper [47] shows that CyberT performs better than
SAM.
The Rank products method [51], implemented
in the RankProd Bioconductor package, is based
on calculating rank products (RP) from replicate
experiments. It is a straightforward and statistically
Figure 2: Detection of differential expression inte-
grating different data pre-filtering and statistics. DE: the
full set of differentially expressed transcripts associated
to a specific biological process. I^III: different integration
of pre-filtering and statistical approaches.
Microarray data analysis and mining approaches 271
 at D
ipartim
ento di Storia dell'U







stringent way to determine the significance level for
each gene and allows for the flexible control of the
false-detection rate and family-wise error rate in the
multiple testing situation of a microarray experiment.
RP is more powerful and accurate for sorting genes
by differential expression than SAM, in particular
with low number of replicates (<10), which are most
commonly used in biological experiments [51].
Furthermore, its relative performance is particularly
strong when the data are contaminated by non-
normal random noise or when the samples are very
non-homogenous [56]. RP does however assume
equal measurement variance for all genes and tends
to give overly optimistic P-values when this assump-
tion is violated. It is therefore essential that proper
variance stabilizing normalization is performed on
the data before calculating the RP values [56].
Where this is impossible, another rank-based variant
of RP (average ranks) provides a useful alternative
with very similar overall performance [56].
Choe results combined with the description of
the limits of SAM and RP suggest that the empirical
bayes statistic [50] probably represents the most
robust way of identifying differential expression in
small experiments designed to have a mechanical
view of a biological treatment.
The definition of the best statistical approach
could however be different if the task is the features
selection for classification purposes. The work of
Jeffery [45] highlights the fact that data set charac-
teristics affect the performances of the applied
statistics. The empirical bayes statistic represents an
accurate way to select features unless datasets have
high pooled variance or a low number of samples.
In this case, RP has been proved useful.
Although two-sample differential expression ana-
lysis is probably the most common experiment,
multi-series time-course microarray experiments are
useful approaches for exploring biological processes.
In these types of experiments, the researcher is
frequently interested in studying gene expression
changes over time and in evaluating trend differences
between the various experimental groups. The large
amount of data, multiplicity of experimental condi-
tions and the dynamic nature of the experiments
pose great challenges to data analysis. A comprehen-
sive review of research in time series expression data
analysis was published by Bar-Joseph in 2004 [57].
Recently, Conesa has published two methods for
time-course microarray data analysis [58, 59]. One is
maSigPro [59], and is part of Bioconductor packages.
This method follows a two-step regression strategy in
order to find genes with significant temporal exp-
ression changes and significant differences between
experimental groups. As a first step, a regression fit
for each gene is computed and the P-value associated
to the F-statistic of the model is computed and
corrected for multiple comparisons by applying FDR
procedure [60]. As a second step, a variable selection
procedure [61] to find significant variables for each
gene is applied. This will ultimately be used to find
what are the profile differences between experi-
mental groups.
The other is ANOVA-SCA [58] and combines
ANOVA-modeling and a dimension reduction
technique to extract targeted signals from data by-
passing structural noise. ANOVA-SCA basically
applies PCA to the estimated parameters in each
source of variation of an ANOVA model. ANOVA-
SCA seems an effective approach for separating the
data variability present in a complex time course
experiment to extract the signal of interest from
noisy data. The selection of significant genes is done
by means of two statistics: leverage and squared
prediction error (SPE). Leverage is a measure of the
importance of a variable (i.e. transcript) in the PCA
model and SPE is a measure of the fit of the model
for that specific gene. High leverage and low SPE
transcripts are transcripts that vary according to the
main trend and correspond to major molecular
functions affected by the treatment. High SPE
transcripts are model diverging data and would
correspond to responsive genes with a minority
pattern. Low leverage transcripts show low variance
and encode functions less specific in the bulk
response.
Angelini and coworkers [62] have recently
described a fully Bayesian approach to detect
differentially expressed genes in time-course experi-
ments. Their approach allows to explicitly use
biological prior information and deals with various
technical difficulties that arise in microarray time-
course experiments such as a small number of
observations, non-uniform sampling intervals, miss-
ing or multiple data and temporal dependence
between observations for each gene. Authors
compared their method with that implemented in
R-package time course [63] and in the EDGE
software [64] claiming that their algorithm provides
results which are much closer to a ‘biologist’s choice’
and delivers a lower percentage of false positive and
negative answers than other algorithms.
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Fischer and coworkers [65] have compared
methods for identifying differentially expressed
genes on time-series microarray data simulated
from artificial gene networks. They suggest the use
of ANOVA variants of Cui and Churchill [66] on
the bases of simulated data and Efron and Tibshirani’s
empirical Bayes Wilcoxon rank sum test [67] in the
case experimental background cannot be effectively
corrected. Shi [68] has instead proposed an approach,
based on a probabilistic continuous hidden process
model (CHPM), to identify the various biological
processes involved in a specific biological experi-
ment. This method integrates time series expression
data with GO biological processes, modelling the
observed gene expression levels as being generated
by a combination of multiple GO biological pro-
cesses whose activity levels vary over time.
BIOLOGICALKNOWLEDGE
EXTRACTION
Extracting clear and coherent hypotheses from
genome-wide expression data remains an important
challenge. Much of the initial work has focused on
the development of techniques for accurate identi-
fication of differentially expressed genes and their
statistical significance in a variety of experimental
designs. However, the main difficulty in analysis lies
not in the identification of differentially expressed
genes but in their interpretation. Attempting to
understand individual genes on a list of significant
genes is demanding and laborious. The problem is
compounded when the pathway of interest involves
moderate effects that are not captured by the genes
near the top of the list. Recent efforts have therefore
focused on the discovery of biological pathways
rather than individual gene function, with the
development of methods that can withstand the
inaccuracies of specific gene estimates and provide a
more expansive view of the underlying processes.
Pathway analysis
Hosack [46], showed that prevalent biological
themes within the set of differentially expressed
transcripts derived from the same experiment, but
using different transcript selection methods, are a
stable representation of the biology underlying the
experiment. Therefore, even though differentially
expressed transcript lists have only partial overlap [46]
they all represent subsets of transcripts associated to a
specific biological event (Figure 2).
A much used database for the functional annota-
tion of transcription profiling is the GO [37]. GO is
however marked by flaws of certain characteristic
types, due to a failure to address basic ontological
principles [69, 70]. This problem has been recently at
least partially overcome thanks to the availability, as
commercial data mining databases, of highly struc-
tured knowledge ontologies. Some of the databases
are produced by automatic extraction of biological
knowledge by means of text mining algorithms, e.g.
Ariadne Genomics’ PathwayStudio (http://www.
ariadnegenomics.com/), others are mainly based
on manual curating, e.g. Ingenuity (www.ingenu
ity.com). The strength of databases such as Ingenuity
is not the availability of new statistical methods
or proprietary graphical algorithms to depict the
relation between functional pathways and differen-
tially expressed transcripts, but the availability of
manually curated and fully traceable data derived
from primary literature sources.
Routinely, both over- and under-representation
of ontology terms can be detected using the standard
hypergeometric test [71]. In probability theory and
statistics, the hypergeometric distribution is a discrete
probability distribution that describes the number of
successes in a sequence of n draws from a finite
population without replacement. The test based on
the hypergeometric distribution is identical to the
corresponding one-tailed version of Fisher’s exact
test. Reciprocally, the P-value of a two-sided
Fisher’s exact test can be calculated as the sum of
two appropriate hypergeometric tests. Even though
ontology enrichment approaches are widely used,
only the most significant portion of the gene list is
used to compute their statistic. Furthermore, the
order of genes on the significant gene list is not taken
into consideration. As a result simply counting the
number of gene set members contained in the short
list leads to loss of information, especially if the list is
long and the difference between the more significant
and the less significant is substantial. Finally, the
correlation structure of gene sets is not considered at
all [72]. More recently, Alexa [73] proposed a
conditional hypergeometric test that computes the
significance of a GO term based on its neighbour-
hood. Using the classical approach in which each
node is scored independently, only few true
significant nodes remain undiscovered. However,
the dependencies between top scoring nodes
yield a high false-positive rate. Alexa introduced
the possibility of weighting genes annotated to a GO
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term based on the scores of neighboring GO terms
or iteratively removing genes mapped to significant
GO terms from more general (higher level) GO
terms. The conditional hypergeometric test based on
GO terms weightings reduces the false-positive rate,
while not missing many true enriched nodes. The
other conditional test is more efficient in finding the
important areas in the GO graph, it also further
reduces the false-positive rate, but with a higher risk
of discarding relevant nodes.
A different use of GO is that applied in the
SemSim Bioconductor package, which allows the
estimation of information content-based similarity
scores of GO terms and gene products [74–76].
GO-based semantic similarity scores can be used to
perform annotation-based clustering as described
by Wolting [77]. Furthermore, the availability of
methods like simUI and simLP in the GOstats
package [71], which allow the estimation of
similarity between lists of differentially expressed
genes derived by the induced GO graphs, can be
extremely useful to detect the presence of common
regulative pathways in meta-analysis experiments
made in different laboratories and/or different
microarray platforms and biological models.
The integration of transcription profiles with biol-
ogy knowledge bases (e.g. GO, KEGG, PUBMED,
etc.) is another way of mapping differentially
expressed transcripts in specific biology knowledge
domains. A coordinated change among many gene
products can produce potent biological effects, while
the effect of each individual transcript can be subtle.
The identification of pathways distinctively enriched
within a set of differentially expressed transcripts
can also be subsequently used to check if more
subtle transcriptional variations, not considered in
the stringent differential expression analysis, could
also be used to strengthen the biological mean of
the identified pathway. Another possible applica-
tion could be the link of alternative splicing
events, detected with the new exon-oriented
Affymetrix microarray platform, to functional path-
ways depicted by conventional differential expres-
sion analysis.
Two of the most used statistics to evaluate the
association between functional pathways and differ-
ential expression are the one-tailed Fisher exact test,
(FET) [46, 78, 79] and Gene Set Enrichment
Analysis (GSEA) [80]. FET is a statistical significance
test used in the analysis of categorical data where
sample sizes are small. The test is used to examine the
significance of the association between two variables
in a 2 2 contingency table. GSEA on the other
hand evaluates microarray data at the level of genesets.
The gene sets are defined based on prior biological
knowledge, e.g. published information about bio-
chemical pathways or co-expression in previous
experiments. The goal of GSEA is to determine
whether members of a gene set S tend to occur
toward the top (or bottom) of the list L, in which
case the gene set is correlated with the phenotypic
class distinction. GSEA acts through three steps:
(i) Calculation of an enrichment score.
(ii) Estimation of significance level of enrichment
score.
(iii) Adjustment for multiple hypothesis testing.
Since an accurate and rapid identification of
perturbed pathways through the analysis of genome-
wide expression profiles facilitates the generation of
biological hypotheses, Tian [81] proposed a statistical
framework for determining whether a specified
group of genes for a pathway has a coordinated
association with a phenotype of interest. In this
framework, the overall objective of the analysis is to
test whether a group of genes has a coordinated
association with a phenotype of interest evaluating
the following two null hypothesis:
(i) The genes in a gene set show the same pattern
of associations with the phenotype compared
with the rest of the genes.
(ii) The gene set does not contain any genes whose
expression levels are associated with the pheno-
type of interest.
After the test statistics are computed for testing the
two hypotheses gene sets are then ranked in order of
their significance and a control for the inflated Type I
error due to multiple comparisons of gene sets is also
applied. The authors claimed that their approach has
more statistical power than currently available
methods and can result in the discovery of statistically
significant pathways that are not depicted by other
methods [81].
Markowetz proposed an algorithm to infer non-
transcriptional pathway features based on differential
gene expression in silencing assays [82]. The author’s
idea is that cellular signalling pathways, which are
not modulated on a transcriptional level, cannot
be directly deduced from expression profiling
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experiments. However, when external interventions
occur i.e. RNA interference or gene knock-outs,
even if the expression of the signalling genes is not
changed, secondary effects in downstream genes shed
light on the pathway, and allow partial reconstruc-
tion of its topology. The core of Markowetz’
approach is the definition of a scoring function,
which measures how well hypotheses about pathway
topology are supported by experimental data.
Promoter analysis
Since microarray data produce a representation of
the effect of a specific treatment on the transcrip-
tional machinery, it is extremely important to link
the transcriptional output signals, measured by
microarray analysis, to promoter elements common
to a subset of differentially expressed genes.
In order to perform this association, it is necessary
to grasp the hidden structure of eukaryotic promo-
ters. Here, we summarize the characteristics of some
of the available methods for transcription-binding
site identification.
The computational discovery of regulatory ele-
ments is humanly possible because they occur several
times in the same genome and because they may be
evolutionarily conserved among different species.
This means that novel regulatory elements may be
discovered by searching for overrepresented motifs
across regulatory regions [83]. This apparently simple
approach is complicated by the fact that most
transcription factor binding sites (TFBSs) are short,
and they can have some variation without loss of
function. Therefore, most motifs are also found as
random hits throughout the genome, and it is a
challenging problem to distinguish between false
positive hits and true positive binding sites. Motif
finding is essentially a signal-to-noise problem. It has
been estimated that in human DNA about 3% of
inter-genic regions are regulatory elements [84]. For
this reason, most algorithms to identify the genomic
regulatory elements use orthogonal data. Several
algorithms include additional prior knowledge about
gene regulation; regulatory elements are not ran-
domly distributed, but tend to form clusters of
regulatory modules [85], and the presence of co-
occurring motifs can be used to identify putative
regulatory modules. Functional sequences are pre-
ferentially conserved over the course of evolution by
selective pressure. This is another characteristic,
along with over-representation, applied by Cora`
[86] to determine TFBSs in the human genome.
The hypothesis that many orthologous genes are
expressed similarly in a tissue-specific manner in
human and mouse and are likely to be co-regulated
by orthologous transcriptional factors (TF) is the base
of the cis-regulatory regions search [87].
Usually, the TFBSs are represented by a ‘consen-
sus sequence’. Consensus sequence has been widely
used to represent the specificity of TF. However, the
consensus sequence is not flexible enough to account
for all variations: in general, it refers to a sequence
that matches all of a site closely, but not necessarily
exactly [88]. An alternative to consensus sequence
is a position weight matrix (PWM) or profile. The
PWM summarizes the statistical properties of
a collection of TF binding sites and represents the
DNA sequences. The PWM is the formalism to
represent DNA motifs bound to a particular TF
because it contains two kinds of knowledge: the
thermodynamic interactions between TF and DNA
and the evolutionary selection [89]. The underlying
assumptions are that natural selection gave rise to a
certain level of sequence specificity for each TF and
that sequences that gave rise to the same physically
binding affinity are equally likely to be selected [90].
A new algorithm to build PWM was implemented
by Foat [91], MatrixREDUCE that uses genome-
wide occupancy data for TF (e.g. ChIP-chip).
A microarray measurement of TF occupancies and
relevant nucleotide sequences for each microarray
feature are used as input to MatrixREDUCE. The
algorithm performs a least-squares fit to a statistical–
mechanical model of TF–DNA interaction, in order
to discover the relative contribution to the free
energy of binding for each nucleotide at each posi-
tion in the generalized TF binding site. The measure
of significance for the PWM is commonly given by











where p is a pattern, L is the pattern length, i is the
index of a base at position j of the PWM, fi,j is the
frequency of the base i at position j of the PWM, and
Pi is the probability of observing that base in the data.
The IC is the weighted average for the binding
energies from each of the sites represented in the
matrix, the lower the IC, the higher the variability in
the site [93].
Currently, there are two comprehensive and
annotated databases that contain information on
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TFs binding site profiles. JASPAR [94] contains a
smaller set that is non-redundant (each TF has only
one profile), while TRANSFAC [95] contains
multiple profile models for some TFs. The discovery
of motifs in sequence data was an early problem to
be addressed in computational biology. The DNA
motif discovery algorithms that have been developed
can be divided into three main groups:
 Complete ab initio methodologies: parameter-free
algorithms for de novo identification of potential
TFBS. This group contains all methodologies that
implement a simple search for the most probable
subsequence in a set of sequences. In this case,
there are no assumptions about the biological
features of the sequences.
 Partial ab initio methodologies: algorithms that
assume some biological knowledge. There are two
categories of algorithms: the first contains algo-
rithms that use ‘complementary information’ (see
below), while the second contains algorithms
which assume that the found subsequences are
possible TFBS, and describes a sequence motif by
means of a position-specific scoring matrix.
 Matrix-based methodologies: algorithms detect
potential TFBS by a sliding window search, with
one specific PWM, of a match subsequences.
An example of a complete ab initiomethodology is
Weeder [96]. This algorithm extends the exhaustive
enumeration of signals without giving as input the
exact length of the patterns to be found. Each motif
is evaluated according to the number of sequences in
which it appears and how well it is conserved in each
sequence with respect to expected values derived
from the oligo frequency analysis of upstream
sequences in the same organism. The algorithm
then compares the top-scoring motifs of each run
with a clustering method to detect which ones could
be more likely to correspond to a TFBS. The
consensus for a set of TFBSs can be seen as a perfect
form recognized by a TF. The algorithm then
enumerates all the possible oligos of the same length
of the motif to be found. For each one, it counts
how many times it appears in the sequences. The
sequences that are overrepresented form a new set of
sequences. It then ranks the motifs found according
to some statistical measure and gives as output the
highest-ranking motifs.
Another algorithm in this category is Yeast Motif
Finder (YMF), written by Sinha [97]. YMF uses an
exhaustive search algorithm to find motifs with the
greatest z-score. The z-score of a motif is the
number of standard deviations by which its observed
number of instances in the actual input sequences
exceeds its expected number of instances.
Both algorithms do not need any input para-
meter. With many parameters to set, the user
explores the parameter space and makes arbitrary
judgment calls on which output to trust. Different
studies have shown the programs to be quite sensitive
to parameters [98].
However, the algorithms that used ‘complemen-
tary information’, as overrepresented in evolution-
arily conserved upstream regions or infer about
co-regulation (GO and results of a set of microarray
experiments), improve the signal/noise ratio by
selecting for analysis those portions of the upstream
regions that are more likely to be functionally
relevant [86]. These methodologies are grouped in
the ‘Partial ab initio’ set. An example is the algorithm
by Caselle [99], where the genome is grouped in sets
based on words that are overrepresented in the
upstream region, and their frequencies in the ref-
erence sample are then compared to the whole
genome. For each of these sets, they compare the
average expression in microarray experiments with
the genome-wide average. If the difference is
statistically significant, the set is a putative TFBS.
Other examples in the ‘Partial ab initio’ set are
algorithms that used a different type of ‘comple-
mentary information’. One example is Consensus.
This algorithm employs a greedy heuristic [100] and
builds up an entire alignment of the sites by adding
in a new one at each iteration. The best alignment of
a potential site is the one with highest information
content. The goal of Consensus is then to determine
a sequence alignment that maximizes log-likelihood
statistics described in a PWM. An expectation-
maximization (EM) method was implemented in the
MEME program [101]. MEME method allows for
the simultaneous identification of multiple patterns,
the starting point derived from each subsequence
occurring in the input sequences. For every sub-
sequence, the algorithm evaluated the quality and
the accuracy of the statistical significance by a pro-
duct of the P-value of column information contents.
In the latter two algorithms, the basic assumption is
that the sequences that are overrepresented in the
genome are putative TFBSs; they then consider the
alignments for every motif as a starting point on
which to build a PWM.
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The third group is a set of methodologies which
search for the presence of a PWM in all sequence
positions using a sliding window approach. One
example is MatInspector [102]: this algorithm detects
potential sequence matches by automatic searches
with a library of pre-compiled matrices. The search
method includes position weighting of the matrices
based on the information content of individual posi-
tions and calculates a relative matrix similarity.
Another example is Patser [103]. This algorithm
computes the numerical estimation of the P-value of
the match score between a subsequence and a
specific matrix. The P-value is the probability of
observing a particular score at a particular sequence
position. The motif with the highest P-value is a
putative TFBS.
Tools allowing the integration of microarray data
with promoter structure information have been
developed [104–109]. The software developed by
Kel [104, 106] is commercially available (Explain
software, www.biobase.de) and uses a genetic algo-
rithm to predict relevant promoters in a set of given
transcripts obtained from microarray analysis, taking
advantage of the promoter element matrix database
TRANSFAC [110–112]. Werner software [107, 108]
is also a commercial tool where promoter elements
are identified usingMatInspector [113]. Tamada [109]
instead has developed a statistical method for esti-
mating gene networks and detecting promoter
elements simultaneously. This method integrates
microarray gene expression data and the DNA
sequence information into a Bayesian network
model. The basic idea of the method is that, if a
parent gene is a TF, its children may share a consensus
motif in their promoter regions of the DNA
sequences. The method detects consensus motifs
based on the structure of the estimated network and
then re-estimates the network using the result of the
motif detection.
Although these data mining tools could enable
a better comprehension of the complex mechanism
of regulation associated to transcription profiling,
it should be pointed out that their main limits are
related to the quality of the promoter level anno-
tation. A statistic comparing the accuracy of the main
tools to discover TFBSs is found in Tompa [114], but
it is very difficult to compare the performance of
methods, in particular on complex genomes like the
human genome.
If sufficient a priori knowledge is available, it is
possible to reconstruct the gene target network for at
least one TF using the method proposed by Barenco
[115], which is based on a mathematical technique
known as hidden variable dynamic modelling
(HVDM). This approach is based on a simple
differential equation model that uses hidden infor-
mation to partially reconstruct, with confidence
intervals, the TF target network. The HVDM takes
advantage of prior biological knowledge to create a
training set of genes, the behaviour of which can be
used to derive the activity profile of the controlling
TF. The method needs quite a lot of input
information, thus rendering its use not easily
generally applicable:
(i) Expression time course microarray data, con-
sisting of at least five time points.
(ii) Some prior biological knowledge about the TF
under review, e.g. at least three genes in the
training set, should be known to be targets of
that TF and presumed to be targets of that TF
only.
(iii) The transcript degradation rate of one of the
known targets, measured in an independent
experiment.
(iv) The technical measurement error for each
expression value should be known.
CONCLUSIONS
In this review, we have touched upon some of the
approaches used for microarray data analysis. The
numerical analysis of microarray is now considerably
consolidated and when new methods appear they
mainly allow for a refinement of the numerical data.
However, the true integration of numerical analysis
and biological knowledge is still a long way off.
The main reason for this lack of integration is the
low amount of functional gene annotation and the
difficulties of the integration of the massive amount
of biological data which are daily published by the
scientific community. A further critical issue in high
eukaryotes data integration is due to data hetero-
geneity, which manifests itself in multiple tiers of
the biological information base and is a major barrier
to progress in the fundamental understanding of
biological processes; an example being that biological
results produced in in-vitro models (e.g. immortalized
cell lines) are very useful for investigating specific
biological events but they are not representative of
the global behavior of a gene in different tissues.
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